Effects of mitogen-activated protein kinase kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro

British Journal of Pharmacology

Volumn 125, Issue 1, 1998, Pages 61-68

  Tsang, F ^a   Koh, A H M ^a   Ting, W L ^a   Wong, P T H ^a   Wong, W S F ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Bronchi; Extracellular signal regulated kinase (ERK); Histamine; LTD4; Mast cell; Mitogen activated protein kinase (MAPK); Mitogen activated protein kinase extracellular signal regulated activating kinase (MEK); Ovalbumin; Peptidoleukotrienes; Schultz Dale reaction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIGEN; ARACHIDONIC ACID; ENZYME INHIBITOR; FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN G ANTIBODY; LEUKOTRIENE D4; MITOGEN ACTIVATED PROTEIN KINASE; OVALBUMIN; PEPTIDOLEUKOTRIENE; PROTEIN TYROSINE KINASE;

AIRWAY; ALLERGIC ASTHMA; ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; GUINEA PIG; HISTAMINE RELEASE; IMMUNOBLOTTING; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SENSITIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION;

ANALYSIS OF VARIANCE; ANIMALS; ASTHMA; BRONCHI; BRONCHOCONSTRICTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; GUINEA PIGS; HISTAMINE RELEASE; HYPERSENSITIVITY; IMMUNOGLOBULIN G; LEUKOTRIENE D4; LUNG; MALE; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OVALBUMIN; PROTEIN KINASE INHIBITORS; PROTEIN KINASES;

EID: 0031656856     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702049     Document Type: Article

References (47)

1. 4 on canine bronchial smooth muscle. Am. J. Physiol., 266, L414-L425.
2. ALBER, G., KENT, U.E. & METZGER, H. (1992). Functional comparison of FcεRI, FcγRII, and FcγRIII in mast cells. J. Immunol., 149, 2428-2436.
3. ALESSI, D.R., CUENDA, A., COHEN, P., DUDLEY, D.T. & SALTIEL, A.R. (1995). PD 09X059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 27489-27494.
4. ARMITAGE, P. & BERRY, G. (1987). Statistical Methods in Medical Research, Blackwell Scientific Publications, Oxford.
5. BEAVEN, M.A. & METZGER, H. (1993). Signal transduclion by Fc receptors: The FcεRI case. Immunol. Today, 14, 222-226.
6. BJORCK, T. & DAHLEN, S.E. (1993). Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: Pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects. Pulm. Pharmacol., 6, 87-96.
7. BOLEN, J.B. (1995). Protein tyrosine kinases in the initiation of antigen receptor signalling. Curr. Opin. Immunol., 7, 306-311.
8. CATLING, A.D., SCHAEFFER, H., REUTER, C.W.M., REDDY, G.R. & WEBER, M.J. (1995). A proline-rich sequence unique to MEK1 and MEK2 is required for Raf binding and regulates MEK function. Mol. Cell Biol., 15, 5214-5225.
9. CHAND, N. & EYRE, P. (1978). The Schultz-Dale reaction: A review. Agent Action, 8, 171-184.
10. COBB, M.H. & GOLDSMITH, E.J. (1995). How MAP kinases are regulated. J. Biol. Chem., 270, 14843-14846.
11. 4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am. J. Physiol., 269, L151-L157.
12. DALE, H.H. (1913). The anaphylatic reaction of plain muscle in guinea pig. J. Pharmacol. Exp. Ther., 4, 167-223.
13. DUDLEY, D.T., PANG, L., DECKER, S.J., BRIDGES, A.J. & SALTIEL, A.R. (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA, 92, 7686-7689.
14. ++ release. J. Pharmacol. Exp. Ther., 280, 1357-1365.
15. DURDEN, D.L., KIM, H.M., CALORE, B. & LIU, Y. (1995). The FcγRI receptor signals through the activation of hck and MAP kinase. J. Immunol., 154, 4039-4047.
16. FRANKLIN, C.C. & KRAFT, A.S. (1997). Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem., 272, 16917-16923.
17. HAY, D.W.P., TORPHY, T.J. & UNDEM, B.J. (1995). Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trend Pharmacol. Sci., 16, 304-309.
18. 2 pathway by FeεRI is not shared by a G protein-coupled receptor. J. Biol. Chem., 270, 10960-10967.
19. +2 signalling and contraction of airway smooth muscle by cyclic AMP-dependent mechanisms. Br. J. Pharmacol., 117, 419-426.
20. ISHIZUKA, T., OSHIBA, A., SAKATA, N., TERADA, N., JOHNSON, G.L. & GELFAND, E.W. (1996). Aggregation of the FcεRI on mast cells stimulates c-Jun aminoterminal kinase activity. J. Biol. Chem., 271, 12762-12766.
21. JIN, N., SIDDIQUI, R.A., ENGLISH, D. & RHOADES, R.A. (1996). Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am. J. Physiol., 271, H1348-1355.
22. JONSSON, E.W. & DAHLEN, S.E. (1994). Interaction between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma. J. Pharmacol. Exp. Ther., 271, 615-623.
23. KATOCH, S.S. & MORELAND, R.S. (1995). Agonist and membrane depolarisation induced activation of MAP kinase in swine carotid artery. Am. J. Physiol., 269, H222-H229.
24. KAWAKAMI, T., INAGAKI, N., TAKEI, M., FUKAMACHI, H., COGGESHALL, K.M., ISHIZAKA, K. & ISHIZAKA, T. (1992). Tyrosine phosphorylation is required for mast cell activation by FcεRI cross-linking. J. Immunol., 148, 3513-3519.
25. KUMLIN, M. & DAHLEN, S.E. (1990). Characteristics of formation and further metabolism of leukotrienes in the chopped human lung. Biochim. Biophys. Acta., 1044, 201-210.
26. KOTLIKOFF, M.I., MURRAY, R.K. & REYNOLDS, E.E. (1987). Histamine-induced calcium release and phorbol antagonism in cultured airway smooth muscle cells. Am. J. Physiol., 253, C561-C566.
27. LANGE-CARTER, C.A., PLEIMAN, C.M., GARDNER, A.M., BLUMER, K.J. & JOHNSON, G.L. (1993). A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science, 260, 315-319.
28. LEPLEY, R.A. & FITZPATRICK, F.A. (1996). Inhibition of mitogen-activated protein kinase kinase blocks activation and redistribution of 5-lipoxygenase in HL-60 cells. Arch. Biochem. Biophys., 331, 141-144.
29. LI, W., DEAMIN, G.G., MARGOLIS, B., SCHLESSINGER, J. & OLIVER, J.M. (1992). FcεRI-mediated tyrosine phosphorylation of multiple proteins, including phospholipase Cγ1 and the receptor βγ2 complex, in RBL-2H3 rat basophilic leukemia cells. Mol. Cell. Biol., 12, 3176-3182.
30. LIN, L.L., WARTMANN, M., LIN, A.Y., KNOPE, J.L., SETH, A. & DAVIS, R.J. (1993). cPLA2 is phosphorylated and activated by MAP kinase. Cell, 72, 269-278.
31. MARAIS, R., LIGHT, Y., PATERSON, H.F. & MARSHALL, C.J. (1995). Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J., 14, 3136-3145.
32. 3 formation in cultured airway smooth muscle. Am. J. Physiol., 257, L209-L216.
33. OLIVER, J.M., BURG, D.L., WILSON, B.S., MCLAUGHLIN, J.L. & GEAHLEN, R.L. (1994). Inhibition of mast cell FcεRI-mediated signalling and effector function by the Syk-selective inhibitor, piceatannol. J. Biol. Chem., 269, 29697-29703.
34. PYNE, S., CHAPMAN, J., STEELE, L. & PYNE, N.J. (1996). Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle. Eur. J. Biochem., 237, 819-826.
35. 1 and IgE antibodies. J. Allergy Clin. Immunol., 87, 1150-1160.
36. ROBINSON, M.J. & COBB, M.H. (1997). Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol., 9, 180-186.
37. ROQUET, A., DAHLEN, B., KUMLIN, M., IHRE, E., ANSTERN, G., BINKS, S. & DAHLEN, S.E. (1997). Combined antagonism of leukotriene and histamine produces predominant inhibition of allergen-induced early and late-phase airway obstruction in asthmatics. Am. J. Respir. Crit. Care Med., 155, 1856-1863.
38. ROSE, D.M., WINSTON, B.W., CHAN, E.D., RICHES, D.W.H., GERWINS, P., JOHNSON, G.L. & HENSON, P.M. (1997). Fcγ receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages. J. Immunol., 158, 3433-3438.
39. SCHARENBERG, A.M. & KINET, J.P. (1994). Initial events in FcεRI signal transduction. J. Allergy Clin. Immunol., 94, 1142-1146.
40. SCHULTZ, W.H. (1910). Physiological studies in anaphylaxis. I. The reaction of smooth muscle of the guinea pig sensitised with horse serum. J. Pharmacol. Exp. Ther., 1, 549-567.
41. SEGER, R. & KREBS, E.G. (1995). The MAPK signaling cascade. FASEB J., 9, 726-735.
42. SONG, J.S., GOMEZ, J., STANCATO, L.F. & RIVERA, J. (1996). Association of a p95 Vav-containing signalling complex with the FcεRI gamma chain in the RBL-2H3 mast cell line. Evidence for a constitutive in vivo, association of Vav with Grb2, Raf-1, and ERK2 in an active complex. J. Biol. Chem., 271, 26962-26970.
43. UNDEM, B.J., BUCKNER, C.K., HARLEY, P. & GRAZIANO, F.M. (1985). Smooth muscle contraction and release of histamine and slow-reacting substance of anaphylaxis in pulmonary tissues isolated from guinea pigs passively sensitized with IgGI or IgE antibodies. Am. Rev Respir. Dis., 131, 260-266.
44. WATTS, S.W. (1996). Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: Use of the mitogen-activated protein kinase kinase inhibitor PD098059. J. Pharmacol. Exp. Ther., 279, 1541-1550.
45. WONG, W.S.F., SPAETHE, S.M., HENRY, D.P. & ELEISCH, J.H. (1992). Contributory role of lung pleura to release of anaphylactic mediators form guinea pig lung in response to ovalbumin or A23187. Biochem. Pharmacol., 44, 1609-1615.
46. WONG, W.S.F., KOH, D.S.K., KOH, A.H.M., TING, W.L. & WONG, P.T.H. (1997). Effects of tyrosine kinase inhibitors on antigen challenge of guinea pig lung in vitro. J. Pharmacol. Exp. Ther., 283, 131-137.
47. ZHANG, C., BAUMGARTNER, R.A., YAMADA, K. & BEAVEN, M.A. (1997). Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-α and release of arachidonic acid in mast cells. J. Biol. Chem., 272, 13397-13402.